LUANN CARYL: Open Payments
NPI 1477058105 · OAKMONT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 13 payments from 9 companies in 2025. Trend: 2023 $744 · 2024 $1,641 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $462 |
| Daiichi Sankyo Inc. | 1 | $142 |
| Neurocrine BioSciences, Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $114 |
| Novo Nordisk Inc | 1 | $113 |
| Lilly USA, LLC | 1 | $96 |
| Verona Pharma, Inc. | 1 | $90 |
| Exact Sciences Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: BREZTRI, INJECTAFER, INGREZZA, AIRSUPRA, Auvelity, Ozempic, KISUNLA, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
